About Premier Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://premierinc.com/
Frequently Asked Questions
What is the 52-week range for PINC?
The 52-week high is $50.2949 and the 52-week low is $27.725.
What is the P/E ratio for PINC?
The P/E ratio data is currently unavailable.
What is the dividend yield for PINC?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -2.09%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -3.28%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.18.
Analyst Recommendation Trends
Wall Street analyst consensus for PINC over the last few months:
Latest PINC News
Tulavi Therapeutics Awarded Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc.
Tulavi Therapeutics has been awarded a national group purchasing agreement and Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc. Effective September 15, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the allay™ Hydrogel Cap, the first and only fully resorbable, in situ forming medical device indicated to reduce the risk of symptomatic neuroma formation. Premi
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
Additions extend BioStem's hospital channel to its BioRetain® wound care linePOMPANO BEACH, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that VENDAJE® and VENDAJE AC® have been added to the Company's existing contracts with Vizient, Inc. and Premier, Inc., two of the nati
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2025-11-25 | Radcliff Bruce J. | -8,621 | - | - |
| 2025-11-25 | Radcliff Bruce J. | -22,535 | $28.25 | $636,614 |
| 2025-11-25 | Zito David P. | -26,916 | - | - |
| 2025-11-25 | Zito David P. | -52,708 | $28.25 | $1,489,001 |
| 2025-11-25 | Alkire Michael J. | -22,694 | - | - |
| 2025-11-25 | Alkire Michael J. | -22,157 | - | - |
| 2025-11-25 | Alkire Michael J. | -64,504 | - | - |
| 2025-11-25 | Alkire Michael J. | -529,432 | $28.25 | $14,956,454 |
| 2025-11-25 | Klatsky David L | -14,514 | - | - |
| 2025-11-25 | Klatsky David L | -79,817 | $28.25 | $2,254,830 |
| 2025-11-25 | Climer Crystal | -5,161 | - | - |
| 2025-11-25 | Climer Crystal | -45,190 | $28.25 | $1,276,618 |
| 2025-11-25 | Brailo Andy | -15,173 | - | - |
| 2025-11-25 | Brailo Andy | -78,693 | $28.25 | $2,223,077 |
| 2025-11-25 | Statuto Richard J. | -42,450 | $28.25 | $1,199,213 |
| 2025-11-25 | O'Quinn Marvin R | -42,450 | $28.25 | $1,199,213 |
| 2025-11-25 | Boudreau Helen M | -18,668 | $28.25 | $527,371 |
| 2025-11-25 | Bigalke John T. | -27,536 | $28.25 | $777,892 |
| 2025-11-25 | Fine Peter | -7,101 | $28.25 | $200,603 |
| 2025-11-25 | Fine Peter | -35,349 | $28.25 | $998,609 |
| 2025-11-25 | Coleman Glenn | -32,018 | - | - |
| 2025-11-25 | Coleman Glenn | -161,464 | $28.25 | $4,561,358 |
| 2025-11-25 | Miller Marc D | -42,450 | $28.25 | $1,199,213 |
| 2025-11-25 | DAVIDS JODY R | -21,033 | $28.25 | $594,182 |
| 2025-11-25 | WOLF ELLEN C | -51,938 | $28.25 | $1,467,249 |
| 2025-11-11 | Coleman Glenn | -3,874 | $28.17 | $109,131 |
| 2025-11-11 | Coleman Glenn | -17,026 | $28.17 | $479,622 |
| 2025-11-01 | Climer Crystal | -1,260 | $28.12 | $35,431 |